Nexalin stockholders elect all directors, approve equity plan amendment and auditor ratification

Nexalin Technology, Inc.

All five director nominees elected; for votes ranged from 6,259,490 to 6,375,246, zero against.
Amendment to 2023 Equity Incentive Plan to increase shares reserved approved: 6,074,244 for, 317,475 against.
Ratification of CBIZ CPAS P.C. as independent auditor for 2025 approved: 10,673,497 for, 99,874 against.
Total shares present at meeting: 11,629,183 of 17,177,929 outstanding.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.